Abattis Bioceuticals Corp. (OTC: AFFBF), a specialty biotechnology company focused on cultivating, licensing and marketing products and services to North American cannabis markets, recently announced the appointment of two new industry experts that could provide some valuable insights to its Board of Directors at its General Annual Meeting (“AGM”) held on June 18, 2014.
“We are excited to have Mr. Fleming and Mr. Montenegrino join our Board of Directors,” said Abattis Bioceuticals Corp. CEO Mike Withrow. “Mr. Fleming’s experience in dealing with aboriginal governments and as the founder of Mernova Medicinal Inc. will be invaluable in developing our own cannabis operations with self-governing nations, while Mr. Montenegrino’s experience overcoming government barriers should be valuable in expeditiously securing licenses.”
Mr. William Fleming is the co-founder of Goose Bay Capital Corporation and the founder of Mernova Medicinal Inc., an Aboriginal-owned company focused on becoming a licensed producer of cannabis in Canada. In the past, he also served as VP of E-Commerce for Bermuda-based GlobeNet Communications, as well as CFO and Director of NWest Energy Corporation.
Mr. Emanuel Montegerino is President and CEO of Think Sharp, a consulting firm for corporations seeking expeditious, creative solutions for their business objectives when facing government barriers. In the past, he served as Chair of the Government Relgions Group of Lang Michener LP, now McMillan LLP, and has 32 years of experience as a business lawyer in the space.
The two new directors will join Messrs. Withrow, Fealey, Sorocco, and Hedley on the Board of Directors, effective immediately. As the company pursues licensed producer status under Canada’s new Marihuana for Medical Purposes Regulations (“MMPR”), the insights from the two new directors could be invaluable when dealing with both the Canadian government and self-governing nations.
Shares of Abattis Bioceuticals Corp. jumped 1.33% in early trading on Friday, June 20, 2014 and are trading up about 1,480% year to date.
Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.